Moreover, another study found that neither BAX expression levels nor BAX/BCL2 ratio was significantly lower in patients who relapsed compared to the initial diagnosis (36), this ratio can be important, because Yu et al, reported the anti-hepatoma effect of curcumin based on increasing the expression of BAX and decreasing the BCL2 expression (37). The gene discussed is BAX; the disease is hepatocellular carcinoma.